PCK2 and neoplasm: Previous studies suggested that downregulation of PCK2 reduced mitochondrial OXPHOS, caused OAA accumulation (Tang et al., 2019), and promoted glycolysis in tumor cells (Chu et al., 2017; Luo et al., 2017).